Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Nasal Obstruction With Oxymetazoline and Corticosteroids [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of oxymetazoline and a nasal corticosteroid for nasal obstruction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal corticosteroid spray (nasal corticosteroid)
  • Oxymetazoline (oxymetazoline)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Nasal Obstruction | Phase 2 | Status: RECRUITING